Indivior Pharmaceuticals Inc
(INDV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 57,000 | -85,000 | 173,000 | 117,000 | 54,000 |
| Depreciation Amortization | 6,000 | 21,000 | 17,000 | 11,000 | 5,000 |
| Accounts receivable | 7,000 | -21,000 | 2,000 | 3,000 | 6,000 |
| Accounts payable and accrued liabilities | 30,000 | -98,000 | -75,000 | -29,000 | -75,000 |
| Other Working Capital | -62,000 | 125,000 | -122,000 | -134,000 | -115,000 |
| Other Operating Activity | -74,000 | 54,000 | 19,000 | -16,000 | 50,000 |
| Operating Cash Flow | $-36,000 | $-4,000 | $14,000 | $-48,000 | $-75,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -33,000 | -245,000 | -233,000 | -171,000 | -150,000 |
| PPE Investments | -125,000 | -5,000 | -4,000 | -2,000 | N/A |
| Sale Of Investment | 36,000 | 27,000 | 15,000 | 10,000 | N/A |
| Purchase Sale Intangibles | -5,000 | N/A | 1,000 | 1,000 | 1,000 |
| Other Investing Activity | -5,000 | 0 | 1,000 | 1,000 | 1,000 |
| Investing Cash Flow | $-127,000 | $-223,000 | $-221,000 | $-162,000 | $-149,000 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -11,000 | -3,000 | -2,000 | -1,000 | -1,000 |
| Common Stock Issued | 2,000 | 2,000 | 2,000 | N/A | 1,000 |
| Common Stock Repurchased | -11,000 | -90,000 | -66,000 | -29,000 | N/A |
| Other Financing Activity | -2,000 | -9,000 | -6,000 | -4,000 | -2,000 |
| Financing Cash Flow | $-22,000 | $-100,000 | $-72,000 | $-34,000 | $-2,000 |
| Exchange Rate Effect | -1,000 | -1,000 | -2,000 | -1,000 | -2,000 |
| Beginning Cash Position | 774,000 | 1,102,000 | 1,102,000 | 1,102,000 | 1,102,000 |
| End Cash Position | 588,000 | 774,000 | 821,000 | 857,000 | 874,000 |
| Net Cash Flow | $-186,000 | $-328,000 | $-281,000 | $-245,000 | $-228,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -36,000 | -4,000 | 14,000 | -48,000 | -75,000 |
| Capital Expenditure | -125,000 | -5,000 | -4,000 | -2,000 | N/A |
| Free Cash Flow | -161,000 | -9,000 | 10,000 | -50,000 | -75,000 |